Cellular Physiology and Biochemistry · 2007 · 18 citations · 49 references
Life SciencesCell BiologyMolecular BiologyEndocytosisMembrane TraffickingMolecular Cell BiologyCellular Drug EffluxCholesterol MetabolismLipid MetabolismMembrane MicrodomainsVesicle FormationCellular Cholesterol HomeostasisCellular Cholesterol TraffickingCholesterol AccumulationCholesterol Depletion EffectsCholesterol EffluxCholesterol Trafficking DefectsCystic Fibrosis GeneticsIntracellular Lipid Accumulation
BACKGROUND/AIMS: F508delCFTR-, but not wtCFTR-, expressing fibroblasts resemble Niemann Pick type C cells in the massive intracellular accumulation of free cholesterol. The recruitment and activation of F508delCFTR by cholesterol depletion was studied. METHODS: Filipin staining, forskolin-stimulated anion efflux and FITC-dextran uptake were studied in control cells and fibroblasts treated with 2-hydroxypropyl beta-cyclodextrin phosphatidylcholine large unilamellar vesicles to deplete cellular free cholesterol. RESULTS: Treatment of F508delCFTR-, but not wtCFTR-, expressing fibroblasts with 2-hydroxypropyl beta-cyclodextrin resulted in a reduction in cellular cholesterol and a potentiation of the forskolin-induced anion efflux. In addition, forskolin also promoted a massive increase in the rate of endocytosis in F508delCFTR fibroblasts, which was absent in genistein- or cyclodextrin-treated cultures. CONCLUSION: The results not only suggest that reducing cellular cholesterol may serve as pharmacotherapeutic tool in the treatment of cystic fibrosis but also reveal a novel mechanism for genistein regulation of F508delCFTR, i.e. retention by inhibition of endocytosis.
49
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Bat-Sheva Kerem, Johanna M. Rommens, Janet A. Buchanan et al. · Science · 1989 · 4.1K citations
Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
Wilfried Dalemans, Pascal Barbry, Guy Champigny et al. · Nature · 1991 · 700 citations